The global pharmaceutical plastic bottle market is expected to reach a valuation of USD 30,051.9 million in 2024 and USD 49,032 million by 2034, growing at a steady CAGR of 5% through 2034. This represents significant growth from the USD 28,854.6 million market size recorded in 2023.

China is projected to account for over 58% of East Asia’s pharmaceutical plastic bottle market. The cost of manufacturing is significantly lower in the country, along with the availability of inexpensive labor and a vast consumer pool, which is attracting many manufacturers.

All these factors have contributed to increasing the supply of pharmaceutical plastic bottles in the market and heightened the level of competition among the pharmaceutical plastic bottle market players. This growth of the healthcare industry is augmenting the innovation and customization in the pharmaceutical packaging industry, in turn bolstering the target market growth.

Explore In-Depth Analysis—Click Here to Access the Report!

Glass is increasingly a preferred material in the manufacturing of pharmaceutical bottles. The manufacturers and the consumers were concerned about the safe handling, storage, and transportation of these bottles, but the unavailability of compatible alternatives kept the demand for glass bottles on the rise.

With innovation and technological advancements, plastic bottles were introduced in the market that were not only able to keep the content intact but also were drastically less fragile. Further, the plastic bottles are light in weight and offer excellent barrier properties against moisture, gas, and solvents. The raw materials used in the manufacturing of these plastic bottles are easily available and are economical as well.

These properties drastically increased the profitability of the manufacturers as it impacted various factors like a decrease in transportation costs, reduction in wastage caused by breakage, and drop in the raw material prices, among others.

Key Takeaways from Global Pharmaceutical Plastic Bottle Market:

• Plastic bottles are anticipated to hold around 44% of the share in 2024 and are further projected to expand with the highest CAGR of 4.1% through 2034.
• Polyethylene terephthalate (PET) is expected to have about 29% of the market share in 2024 and reach a valuation of USD 15.8 billion by the assessment period.
• Polyethylene (PE) bottles are growing rapidly with a CAGR of 4.3%, expanding 1.6 times its current market value over the forecast period.
• Below 100 ml pharmaceutical plastic bottles are projected to contribute USD 14.8 million in revenue in 2024 and capture almost 53% of the market share by 2034.
• 100 ml to 250 ml range is the dominant segment anticipated to expand at a CAGR of 4% contributing USD 3.7 billion incremental dollar opportunity during the assessment period.
• Europe is the major shareholder in the pharmaceutical plastic bottles industry with almost 28% of the value share, and is expected to reach a USD 12.2 billion valuation by 2034.
• East Asia is expected to contribute USD 4.7 billion, while South Asia is projected to grow at 6.3% by 2034.

Competitive Landscape:

Some companies in the pharmaceutical plastic bottle market are also working on introducing NFC technology to further enhance consumer experience and improve the supply-chain management. Launching innovative pharmaceutical plastic bottles in the market can prove to be an incredible opportunity for manufacturers to capture maximum market share in the industry.

Key Players of Pharmaceutical Plastic Bottle Manufacturers:

• Berry Global Inc.
• Amcor Plc
• Gerresheimer AG
• AptarGroup, Inc
• Alpha Packaging Company
• Mykron Plus India Pvt. Ltd.
• Comar LLC
• Alpack Inc.
• Drug Plastics Group
• ALPLA Werke Alwin Lehner GmbH & Co KG
• Bormioli Pharma S.p.a.
• C.L.Smith Company
• United States Plastic Corporation
• Weener Plastics Group BV
• Origin Pharma Packaging
• Pretium Packaging
• Pro-Pac Packaging Group
• Silgan Holdings Inc
• Frapak Packaging b.v.
• Altium Packaging

Global Pharmaceutical Plastic Bottle Market Report:

Future Market Insights, in its new report, offers an unbiased analysis of the global market for pharmaceutical plastic bottles, analyzing historical demand from 2019 to 2023 and forecast statistics for 2024 to 2034.

The study reveals market growth projections based on bottle type (plastic bottles for solid formulations, plastic bottles for liquid formulations, and plastic bottles for ophthalmic or nasal formulations), material (polyethylene terephthalate (PET), polypropylene (PP), polyethylene (PE) (low density polyethylene, and high density polyethylene), and polyvinyl chloride (PVC)), and capacity (below 100 ml, 100 to 250 ml and above 250 ml).

Key Segments of Pharmaceutical Plastic Bottle Market

By Bottle Type:

The industry is segregated into plastic bottles for solid formulations, plastic bottles for liquid formulations, and plastic bottles for ophthalmic or nasal formulations.

By Material:

In terms of material, the industry is divided into polyethylene terephthalate (PET), polypropylene (PP), polyethylene (PE), and polyvinyl chloride (PVC). Polyethylene is further segmented as low density polyethylene (LDPE) and high density polyethylene (HDPE).

By Capacity:

Few of the important capacities include below 100 ml, 100 to 250 ml and above 250 ml.

By Region:

Key countries of North America, Latin America, South Asia, East Asia, Europe, Oceania, and the Middle East and Africa are covered.